233 related articles for article (PubMed ID: 16597536)
1. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.
van Kooij B; Rothova A; de Vries P
Ocul Immunol Inflamm; 2006 Apr; 14(2):73-85. PubMed ID: 16597536
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
[TBL] [Abstract][Full Text] [Related]
4. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
[TBL] [Abstract][Full Text] [Related]
8. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
10. Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children.
Sallam A; Comer RM; Chang JH; Grigg JR; Andrews R; McCluskey PJ; Lightman S
Arch Ophthalmol; 2008 Feb; 126(2):200-5. PubMed ID: 18268210
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.
Maca SM; Abela-Formanek C; Kiss CG; Sacu SG; Benesch T; Barisani-Asenbauer T
Clin Exp Ophthalmol; 2009 May; 37(4):389-96. PubMed ID: 19594566
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
13. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Galor A; Margolis R; Brasil OM; Perez VL; Kaiser PK; Sears JE; Lowder CY; Smith SD
Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
[TBL] [Abstract][Full Text] [Related]
14. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
15. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A
Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.
Hogewind BF; Zijlstra C; Klevering BJ; Hoyng CB
Eur J Ophthalmol; 2008; 18(3):429-34. PubMed ID: 18465727
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.
Atmaca LS; Yalçindağ FN; Ozdemir O
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):451-6. PubMed ID: 17226025
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.
Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S
Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038
[TBL] [Abstract][Full Text] [Related]
20. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
